PRGO
50
3
M
12
6
WBA
29
2
CPB
55
8
K
65
3
IR
65
2
LB
52
3
MMC
65
-2
HSY
40
2
MO
38
2
FSLR
64
-6
HBI
62
4
NTRS
44
5
CHRW
44
2
OMC
62
14
MTB
57
4
NI
67
2
GD
62
2
AMP
63
3
PYPL
41
-2
PRGO
50
3
M
12
6
WBA
29
2
CPB
55
8
K
65
3
IR
65
2
LB
52
3
MMC
65
-2
HSY
40
2
MO
38
2
FSLR
64
-6
HBI
62
4
NTRS
44
5
CHRW
44
2
OMC
62
14
MTB
57
4
NI
67
2
GD
62
2
AMP
63
3
PYPL
41
-2
Financhill
Back

GeneDx Holdings 10K Form

Sell
39

WGS
GeneDx Holdings

Last Price:
37.81
Seasonality Move:
-60.58%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive WGS News And Ratings

See the #1 stock for the next 7 days that we like better than WGS

WGS Financial Statistics

Sales & Book Value

Annual Sales: $202.57M
Cash Flow: $-5.86M
Price / Cash Flow: 0
Annual Sales: $7.21
Price / Book: 5.26

Profitability

EPS (TTM): -4.44000
Net Income (TTM): $-117.47M
Gross Margin: $90.01M
Return on Equity: -49.79%
Return on Assets: -28.02%

GeneDx Holdings Earnings Forecast

Key GeneDx Holdings Financial Ratios

  • The Gross Profit Margin over the past 5 years for WGS is 44.43%.
  • The Selling, General & Administrative Expenses for WGS have been equal to 96.12% of Gross Profit Margin.
  • The Research & Development expenses have been 28.76% of Revenue.
  • The Interest Expense is -0.58% of Operating Income.
  • The Net Earning history of WGS is -86.77% of Total Revenues.
  • Per Share Earnings over the last 5 years have been positive in 2 years.

GeneDx Holdings Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Providers & Services
Sector: Health Care
Current Symbol: WGS
Website: genedx.com

Debt

Debt-to-Equity Ratio: 0.27
Current Ratio: 2.38
Quick Ratio: 1.95

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 398.63

WGS Technical Analysis vs Fundamental Analysis

Sell
39
GeneDx Holdings (WGS) is a Sell

Is GeneDx Holdings a Buy or a Sell?

  • GeneDx Holdings stock is rated a Sell
    The current GeneDx Holdings [WGS] share price is $37.87. The Score for WGS is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.